Glenn Sblendorio - Net Worth and Insider Trading

Glenn Sblendorio Net Worth

The estimated net worth of Glenn Sblendorio is at least $18 Million dollars as of 2024-11-13. Glenn Sblendorio is the CEO of IVERIC bio Inc and owns about 244,138 shares of IVERIC bio Inc (ISEE) stock worth over $10 Million. Glenn Sblendorio is the President & CFO of The Medicines Co and owns about 99,805 shares of The Medicines Co (MDCO) stock worth over $8 Million. Glenn Sblendorio is also the Director of Amicus Therapeutics Inc and owns about 11,933 shares of Amicus Therapeutics Inc (FOLD) stock worth over $125,177. Details can be seen in Glenn Sblendorio's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Glenn Sblendorio has not made any transactions after 2022-12-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Glenn Sblendorio

To

Glenn Sblendorio Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Glenn Sblendorio owns 5 companies in total, including Amicus Therapeutics Inc (FOLD) , Intercept Pharmaceuticals Inc (ICPT) , and IVERIC bio Inc (ISEE) among others .

Click here to see the complete history of Glenn Sblendorio’s form 4 insider trades.

Insider Ownership Summary of Glenn Sblendorio

Ticker Comapny Transaction Date Type of Owner
FOLD Amicus Therapeutics Inc 2015-07-13 director
ICPT Intercept Pharmaceuticals Inc 2020-05-28 director
ISEE IVERIC bio Inc 2022-12-19 director
LIMIT LIMIT 2015-09-03 director & President & CFO
LIMIT LIMIT 2023-09-13 director

Glenn Sblendorio Latest Holdings Summary

Glenn Sblendorio currently owns a total of 3 stocks. Among these stocks, Glenn Sblendorio owns 244,138 shares of IVERIC bio Inc (ISEE) as of December 19, 2022, with a value of $10 Million and a weighting of 53.15%. Glenn Sblendorio owns 99,805 shares of The Medicines Co (MDCO) as of September 3, 2015, with a value of $8 Million and a weighting of 46.17%. Glenn Sblendorio also owns 11,933 shares of Amicus Therapeutics Inc (FOLD) as of July 13, 2015, with a value of $125,177 and a weighting of 0.68%.

Latest Holdings of Glenn Sblendorio

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ISEE IVERIC bio Inc 2022-12-19 244,138 39.95 9,753,313
MDCO The Medicines Co 2015-09-03 99,805 84.90 8,473,445
FOLD Amicus Therapeutics Inc 2015-07-13 11,933 10.49 125,177

Holding Weightings of Glenn Sblendorio


Glenn Sblendorio Form 4 Trading Tracker

According to the SEC Form 4 filings, Glenn Sblendorio has made a total of 12 transactions in IVERIC bio Inc (ISEE) over the past 5 years, including 2 buys and 10 sells. The most-recent trade in IVERIC bio Inc is the sale of 19,457 shares on December 19, 2022, which brought Glenn Sblendorio around $418,520.

According to the SEC Form 4 filings, Glenn Sblendorio has made a total of 0 transactions in The Medicines Co (MDCO) over the past 5 years. The most-recent trade in The Medicines Co is the sale of 25,000 shares on September 3, 2015, which brought Glenn Sblendorio around $1 Million.

According to the SEC Form 4 filings, Glenn Sblendorio has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 10,000 shares on July 13, 2015, which brought Glenn Sblendorio around $150,000.

Insider Trading History of Glenn Sblendorio

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Glenn Sblendorio Trading Performance

GuruFocus tracks the stock performance after each of Glenn Sblendorio's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Glenn Sblendorio is 26.72%. GuruFocus also compares Glenn Sblendorio's trading performance to market benchmark return within the same time period. The performance of stocks bought by Glenn Sblendorio within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Glenn Sblendorio's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Glenn Sblendorio

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 39.89 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 37.9 LIMIT LIMIT LIMIT LIMIT LIMIT

Glenn Sblendorio Ownership Network

Ownership Network List of Glenn Sblendorio

No Data

Ownership Network Relation of Glenn Sblendorio

Insider Network Chart

Glenn Sblendorio Owned Company Details

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Glenn Sblendorio is the director of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Glenn Sblendorio made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 232,762 shares made by Bradley L Campbell , a net sale of 333,235 shares made by John F Crowley , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 30,401 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 30,401 shares. During the past 18 months, 803,781 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 803,781 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amicus Therapeutics Inc Insider Transactions

No Available Data

Glenn Sblendorio Mailing Address

Above is the net worth, insider trading, and ownership report for Glenn Sblendorio. You might contact Glenn Sblendorio via mailing address: 3 Times Sqaure, 12th Floor, New York Ny 10036.